InvestorsHub Logo
Followers 34
Posts 2222
Boards Moderated 0
Alias Born 07/28/2017

Re: None

Thursday, 12/26/2019 11:09:05 AM

Thursday, December 26, 2019 11:09:05 AM

Post# of 203913
Market cap still too low at 10 million. With their first real patent, and being a US patent, market cap should be 50-100 million. The price came down way too low, I believe the sector brought it down just like 99% of other cannabis stocks on the OTC, but went much lower due to the Jeff Freidland events and lack of positive news.

I think even if the company does nothing new, simply just continues their long process of clinical trials, they will be worth so much more just because they probably now have big pharma's attention. What other company has a patent on any drug or potential drug with real THC? I don't think any other companies on the OTC, only NASD, correct me if I'm wrong.